COVID-19 Response 

Access our COVID-19 Response homepage, with more information and resources during the COVID-19 pandemic, including what to do if you’re experiencing symptoms.

Baylor College of Medicine

Leveraging Ethical Dissension Among Capacity, Beneficence And Justice In Clinical Trials Of Neurotherapeutics In The Severely Disabled: Lessons From Schizophrenia (H-46685 )



This study is being done to learn the ethical principles of consenting and understanding the process of the deep brain stimulation in patients with Treatment- Resistant Schizophrenia as well as patients with Parkinson’s Disease. This study focuses on the capacity of consent in patients with Schizophrenia/Parkinson’s disease and to reduce disparities that may decrease access to treatments such as deep brain stimulation (DBS).

Deep Brain Stimulation treatments are an effective alternative to medication, especially in patients that have not had success with their medications. After patients complete phase 1 of the study which includes consenting to DBS treatment, TRS patients will get an opportunity to participate in phase 2 of this study for DBS treatments if they qualify.

This study is only one visit and all patients will be compensated for travel and time. Patients must have either a diagnosis of Schizoaffective/Schizophrenia for one year or Parkinson’s disease. Caregivers for patients interested in this study are also invited to participate. 


Maryam Anis

Phone 1: 346–266–8167

IRB: H-46685




Back to topback-to-top